Updated:
Avista Pharma Solutions
Avista Pharma Solutions is a contract development, manufacturing, and testing organization formed from Array BioPharma's CMC business and Scynexis' contract...
Avista Pharma Solutions
Avista Pharma Solutions is a contract development, manufacturing, and testing organization formed from Array BioPharma's CMC business and Scynexis' contract services business. The company provides services including early stage discovery, API and Drug Product development, cGMP manufacturing, and analytical and microbiology testing. These services span the development and testing process.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Eagan
Corporate office
Eagan, MN, United States
Additional offices
Longmont, CO, United States · Agawam, MA, United States
Sector focus
Frequently asked questions
What services does Avista Pharma Solutions provide?
Avista Pharma Solutions operates as a contract development and manufacturing organization (CDMO), offering analytical testing, formulation development, and clinical-trial material production for small-molecule and biologic pharmaceutical products (per public record).
Where are Avista Pharma Solutions' facilities located?
The firm maintains facilities in three US locations: Eagan, Minnesota; Longmont, Colorado; and Agawam, Massachusetts (per the firm's official communications).
Is Avista Pharma Solutions a family office or investment firm?
Avista Pharma Solutions is a pharmaceutical services company, not a family office or investment firm. It provides CDMO services to drug developers and does not manage third-party capital or make investment allocations (per public record).
Who owns Avista Pharma Solutions?
The ownership structure of Avista Pharma Solutions is not publicly documented. No parent company, private equity sponsor, or family ownership has been disclosed in public records.
What pharmaceutical stages does Avista Pharma Solutions serve?
The firm serves drug developers across early-stage research through clinical-trial material production and commercial manufacturing, focusing on both small-molecule and biologic products (per public record).
Does Avista Pharma Solutions report AUM or financial metrics?
Avista Pharma Solutions does not publicly disclose AUM, revenue, or investment-related financial metrics. The company appears to operate as a service-based CDMO rather than an investment fund.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: